Enhanced Paclitaxel Efficacy to Suppress Triple-Negative Breast Cancer Progression Using Metronomic Chemotherapy with a Controlled Release System of Electrospun Poly-d-l-Lactide-Co-Glycolide (PLGA) Nanofibers

SIMPLE SUMMARY: Treatment of metastatic triple-negative breast cancer (TNBC) relies on chemotherapy. To improve the efficacy of chemotherapy and avoid systemic toxicity, metronomic chemotherapy using continuous administration of low-dose chemotherapy could be a solution. The paclitaxel-loaded PLGA n...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ming-Yi, Hsieh, Cheng-Hsien, Huang, Yu-Ting, Chu, Sung-Yu, Chen, Chien-Ming, Lee, Wei-Jiunn, Liu, Shih-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268060/
https://www.ncbi.nlm.nih.gov/pubmed/34283075
http://dx.doi.org/10.3390/cancers13133350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268060/
https://www.ncbi.nlm.nih.gov/pubmed/34283075
http://dx.doi.org/10.3390/cancers13133350

Ejemplares similares